Evidence map›Paper›PMID 42272702›Full record

ArticleWellcome open research2025

Unified framework for the ingestion of early epidemic data for downstream data analytics.

Everlyn Kamau, Sadie Kelly, Dhruv Darji, Amrish Y Baidjoe, John S Brownstein, Finlay Campbell, Abhishek Dasgupta, Marie-Amélie Degail, Anastasiia Demidova, Luca Ferretti and 12 more

Abstract read
In one paragraph

Article in Wellcome open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Everlyn KamauFrancis I. Proctor Foundation, University of California San Francisco, San Francisco, California, USA.ORCID https://orcid.org/0000-0003-4285-2255
Sadie KellyDepartment of Biology, University of Oxford, Oxford, England, UK.
Dhruv DarjiNuffield Department of Medicine, University of Oxford, Oxford, England, UK.
Amrish Y BaidjoeMedecins Sans Frontieres, Operational Centre Brussels (OCB), Brussels, Belgium.
John S BrownsteinComputational Epidemiology Lab, Boston Children's Hospital, Boston, USA.
Finlay CampbellWHO Hub for Pandemic and Epidemic Intelligence, Berlin, Germany.ORCID https://orcid.org/0000-0002-1849-1886
Abhishek DasguptaDepartment of Biology, University of Oxford, Oxford, England, UK.ORCID https://orcid.org/0000-0003-4420-0656
Marie-Amélie DegailWorld Health Organization, Geneva, Switzerland.
Anastasiia DemidovaIndependent Researcher, Limassol, Cyprus.
Luca FerrettiNuffield Department of Medicine, University of Oxford, Oxford, England, UK.
Aimee HanComputational Epidemiology Lab, Boston Children's Hospital, Boston, USA.ORCID https://orcid.org/0000-0001-8927-3432
Stephen Leshan KoyieWorld Health Organization, Geneva, Switzerland.
Patricia Ndumbi NgamalaWorld Health Organization, Geneva, Switzerland.
Olivier Le PolainWorld Health Organization, Geneva, Switzerland.
Amanda RojekNuffield Department of Medicine, University of Oxford, Oxford, England, UK.ORCID https://orcid.org/0000-0002-3948-0756
Jacquelin SauerDepartment of Community Health Sciences, Boston University School of Public Health, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0001-5694-8392
Samuel V ScarpinoInstitute for Experiential AI, Northeastern University, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0001-5716-2770
Kara SewalkComputational Epidemiology Lab, Boston Children's Hospital, Boston, USA.
Juliana SopkoComputational Epidemiology Lab, Boston Children's Hospital, Boston, USA.
Stanislaw ZakrzewskiTechnical University of Lodz, Lodz, Poland.ORCID https://orcid.org/0000-0003-2879-8678
Laura MersonPandemic Sciences Institute, University of Oxford, Oxford, England, UK.ORCID https://orcid.org/0000-0002-4168-1960
Moritz U G KraemerDepartment of Biology, University of Oxford, Oxford, England, UK.ORCID https://orcid.org/0000-0001-8838-7147

Funding

Wellcome Trust
6 · The paper itself

Abstract

Background: Early-phase data during an epidemic are often heterogeneous and difficult to integrate across systems, therefore a need for standard tools and reporting guidelines to facilitate timely and reliable data collection. The Global.health team have developed a data schema for the ingestion of epidemic data, allowing interoperability where data curated to this schema are readily ingested into existing systems for analysis. This paper describes the definition of 'core data' within the Global.health schema to focus data collection on the most relevant and available data to inform epidemic response during the first 100 days of an outbreak. Methods: We used expert consultation and a structured literature review to identify key epidemiological questions and parameters that must be addressed during the first 100 days of an outbreak. Relevant digital toolkits and reporting frameworks were reviewed, and minimum data variables required for parameter estimation were identified. These variables were mapped to the existing Global.health schema and assessed for availability in early outbreak data from four recent epidemics. Variables were categorized by availability and those with sufficient early availability were retained in a proposed core schema. Data formats were harmonized with WHO Epi Core, T0 and T1 toolkits to enhance interoperability. A complementary modular schema was defined to capture pathogen-specific variables. Results: The literature review yielded 78 key epidemiological parameters relevant to early outbreak assessment, organized into eleven categories. Analysis of variable availability in early outbreak datasets showed that 42 of 140 variables in the existing Global.health schema were consistently available and suitable for inclusion in a core early-epidemic schema. Variables related to demographics, case status, symptom reporting, confirmation dates, outcomes, and exposure history were frequently available, while vaccination history, detailed treatment data, and certain clinical variables were less consistently reported. The resulting core schema comprises 42 interoperable variables across seven domains and aligns with WHO data standards and controlled terminologies. Conclusions: Standardized, interoperable data capture during the early phase of epidemics is essential to enable timely estimation of key epidemiological parameters and to inform response strategies. The Global.health core schema provides a minimum, evidence-informed dataset for early outbreak investigation while maintaining compatibility with WHO reporting standards. By prioritizing variables that are both epidemiologically critical and realistically available in early data streams, this framework supports improved data harmonization, analysis, and decision-making during the first 100 days of an epidemic.

Indexed as

Data SchemaEpidemicOutbreakReporting GuidelinesToolkits

Identifiers

PMID42272702
PMCPMC13247574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.